Paperonium

HIV care · Lancet Reg Health Eur · 2024

The summary shrinks uncontrolled HIV’s death risk and inflates TB’s by quoting the wrong table lines

Summary: uncontrolled HIVTable: a test result missing,source of the summary’s 4.2Table: uncontrolled HIVnot 4.2Summary: TB before orat joining3.3 times the death rateTable: TB during the study,source of the summary’s 3.3Table: TB before or at joining1.5 times, not 3.34.2×3.395.27.61×6.688.682.754.031.261.671×2×5×10×same death rate
Summary:uncontrolled HIVTable: a test resultmissing, source ofthe summary’s 4.2Table:uncontrolled HIVnot 4.2Summary:TB beforeor at joining3.3 times thedeath rateTable: TB duringthe study, sourceof thesummary’s 3.3Table: TB beforeor at joining1.5 times, not 3.34.2×3.395.27.61×6.68 to 8.682.754.031.26 to 1.671×2×5×10×same death rate

Death rate as a multiple of the reference group’s; bars show likely ranges

The paper says

The paper’s summary says that among 20,364 people with HIV, uncontrolled HIV (few immune cells, virus not kept down) came with 4.2 times the death rate of well-controlled HIV, and tuberculosis (TB) before or at joining the study 3.33 times that of no TB.

Its own data show

Its table gives 7.61 times for uncontrolled HIV (true figure likely between 6.68 and 8.68) and 1.45 (likely 1.26 to 1.67) for TB before or at joining. The summary’s numbers, ranges included, belong to two other lines, as its results section confirms: people missing an immune-cell or virus test, and TB during the study.

Each table line compares one group’s death rate with a reference group: well-controlled HIV for the HIV lines, no TB for the TB lines. The summary, the part most readers use, puts the uncontrolled-HIV figure almost half too low and the TB figure more than twice too high. Both still go with more deaths; only the sizes are wrong.

“The summary” means the paper’s abstract: the short summary printed at its top, which is the part most readers see.

Read the paper →Full technical write-up →

All-cause and AIDS-related mortality among people with HIV across Europe from 2001 to 2020: impact of antiretroviral therapy, tuberculosis and regional differences in a multicentre cohort study · Lancet Reg Health Eur (2024) · doi:10.1016/j.lanepe.2024.100989